MAPK inhibition in BRAFV600E CRC.

doi:10.1038/s41575-023-00756-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

MAPK inhibition in BRAFV600E CRC.

Nature reviews. Gastroenterology & hepatology - 1 Apr 2023

Kotsiliti Eleni

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Colorectal Neoplasms
Share to Mutation
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 36788354
DOI: 10.1038/s41575-023-00756-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MAPK inhibition in BRAFV600E CRC.PMID 36788354Read ↗

BRAF as a target for cancer therapy.Semantic proximity Read ↗

BRAF inhibitors in clinical oncologySemantic proximity Read ↗

Therapeutic strategies for inhibiting oncogenic BRAF signaling.Semantic proximity Read ↗

Advances on the BRAF Front in Colorectal Cancer.Semantic proximity Read ↗

New therapeutic strategies for BRAF mutant colorectal cancers.Semantic proximity Read ↗

Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated TumoursSemantic proximity Read ↗

The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancerSemantic proximity Read ↗

Targeting MAPK in Cancer 2.0Semantic proximity Read ↗

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers.Semantic proximity Read ↗

Current Insights of BRAF Inhibitors in Cancer.Semantic proximity Read ↗

Resistance to BRAF inhibition in melanomas.Semantic proximity Read ↗

Molecular Pathways and Mechanisms of BRAF in Cancer Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.